Tag Archives: weight gain in carcinoid patients

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to a … Continue reading

Posted in carcinoid and neuroendocrine tumor conferences, carcinoid and neuroendocrine tumor treatments, carcinoid doctors, carcinoid testing, liver cancer treatments, neuroendocrine cancer, neuroendocrine tumors, nuclear imaging, nuclear medicine tests, rare cancers, rare diseases, resources for carcinoid and NET patients | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments